Welcome to Inventiva Pharma

No front page content has been created yet.

Inventiva

Latest News

Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update
Inventiva Announces Positive DSMB Reviews in both NASH and Systemic Sclerosis Phase IIb Trials with Lanifibranor
FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study of Lanifibranor in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease